Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
12/22/1994 | WO1994029308A1 Lavendamycin analogs, their use and preparation |
12/22/1994 | WO1994029295A1 Heterocyclic derivatives with immunomodulating activity |
12/22/1994 | WO1994029288A1 Δ6,7-taxols antineoplastic use and pharmaceutical compositions containing them |
12/22/1994 | WO1994028916A1 Release and mobilisation of haematopoietic cells |
12/22/1994 | WO1994028909A1 Antineoplastic compositions and methods of use |
12/22/1994 | WO1994028875A1 Compositions for boron neutron capture therapy and methods thereof |
12/22/1994 | WO1994025588A3 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β) |
12/22/1994 | WO1994025477A3 Novel peptide nucleic acids |
12/22/1994 | WO1994017773A3 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
12/22/1994 | CA2164811A1 Super proteins including interferons and interleukins |
12/22/1994 | CA2164314A1 Cephalostatin analogues and their use as anti-tumour agents |
12/22/1994 | CA2164288A1 Method for treating kaposi's sarcoma with antisense oligonucleotides |
12/22/1994 | CA2163905A1 Inhibiting protein interactions |
12/22/1994 | CA2162995A1 Compositions for boron neutron capture therapy and methods thereof |
12/22/1994 | CA2161328A1 Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them |
12/21/1994 | EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them |
12/21/1994 | EP0629238A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
12/21/1994 | EP0629211A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation |
12/21/1994 | CN1096584A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of hla-c-clone 10/mage-1 derived peptides, and method for treating said......... |
12/21/1994 | CN1027065C Tetralin esters of phenols or benzoic acids |
12/20/1994 | US5374746 L-talopyranoside derivatives and process for the preparation of same |
12/20/1994 | US5374739 Mitomycin analogs |
12/20/1994 | US5374711 Chemical modification of 2"-amino group in elsamicin a |
12/20/1994 | US5374656 N-phenyl-n-alkoxycarbonylalkyl glycinamides, their preparation and the medicaments containing them |
12/20/1994 | US5374652 Substituted naphthylmethylene- or tetrahydronaphthylmethylene-derivatives of 2-oxoindole |
12/20/1994 | US5374629 Vitamin D analogues |
12/20/1994 | US5374549 Treating tumors; culturing with suppression of expansion of adherent lymphokine-activated killer(A-LAK) cells |
12/20/1994 | CA1333647C Heptapeptide analogs of somatostatin |
12/20/1994 | CA1333616C 19-nor-vitamin d compounds |
12/20/1994 | CA1333602C Metalloporphyrin derivatives, their preparation, their application as medecines and their use for the preparation of hybrid molecules |
12/18/1994 | CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them |
12/14/1994 | EP0628639A1 Reconstituted human antibody against human interleukin 6 receptor |
12/14/1994 | EP0628550A2 Pyridazines as interleukin-1beta converting enzyme inhibitors |
12/14/1994 | EP0628315A1 Lectin complex and probe and method for making same |
12/14/1994 | EP0628309A1 Use of O-esters of L-carnitine for the treatment of dermatoses |
12/14/1994 | EP0628055A1 Modified tcf |
12/14/1994 | EP0628054A1 Car receptors and related molecules and methods |
12/14/1994 | EP0628038A1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION |
12/14/1994 | EP0627940A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells |
12/14/1994 | EP0627921A1 Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof |
12/14/1994 | EP0627917A1 Cytoprotective compositions containing pyruvate and antioxidants |
12/14/1994 | EP0543864B1 Novel vitamin d analogues |
12/14/1994 | EP0498830B1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation |
12/14/1994 | EP0496813B1 Liposome microreservoir composition and method |
12/14/1994 | EP0471030B1 Glycoprotein hormone receptor molecules |
12/14/1994 | EP0382840B1 Aloe compositions and uses thereof |
12/14/1994 | EP0380607B1 Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen |
12/14/1994 | CN1096197A Compositions containing esters of unsaturated fatty acids |
12/14/1994 | CN1026984C Process for the preparation of distamycin derivatives |
12/13/1994 | US5373093 Suitable in preparation of reproter molecules and for magnetic resonance, radiation imaging and and radiation therapy |
12/13/1994 | US5373024 3,5-Substituted benzoylguanidines, process for their preparation, their use as a medicament of diagnostic and medicament containing them |
12/13/1994 | US5372809 Antigenic matrix metalloproteinase peptides |
12/13/1994 | US5372808 Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
12/09/1994 | CA2125359A1 Pyridazines as interleukin-1.beta.-converting enzyme inhibitors |
12/08/1994 | WO1994028391A1 Ligands for flt3 receptors |
12/08/1994 | WO1994028023A1 Cell surface protein expressed on human cortical thymocyte and their use |
12/08/1994 | WO1994028016A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1) |
12/08/1994 | WO1994028015A1 Lhrh antagonists |
12/08/1994 | WO1994028014A2 Peptide inhibitors of urokinase receptor activity |
12/08/1994 | WO1994027990A1 INDOLE DERIVATIVES AS STEROID 5α-REDUCTASE INHIBITORS |
12/08/1994 | WO1994027989A1 Carbazole derivatives with 17,20-lyase-inhibiting activity |
12/08/1994 | WO1994027984A1 Taxane having antitumor activity |
12/08/1994 | WO1994027982A1 Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
12/08/1994 | WO1994027979A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
12/08/1994 | WO1994027954A1 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents |
12/08/1994 | WO1994027637A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
12/08/1994 | WO1994027635A1 Compositions and methods for treating cancer and hyperproliferative disorders |
12/08/1994 | WO1994027632A1 Cell growth regulators |
12/08/1994 | WO1994027595A1 Tri(platinum) complexes |
12/08/1994 | WO1994027585A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
12/08/1994 | WO1994027584A2 Arylating medicaments |
12/08/1994 | WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
12/08/1994 | WO1994024163A3 Bispecific antigen-binding molecules |
12/08/1994 | CA2163741A1 Peptide inhibitors of urokinase receptor activity |
12/08/1994 | CA2163652A1 Compositions and methods for treating cancer and hyperproliferative disorders |
12/08/1994 | CA2163638A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
12/08/1994 | CA2163459A1 Arylating medicaments |
12/08/1994 | CA2163225A1 Lhrh antagonists |
12/08/1994 | CA2162921A1 Carbazole derivatives with 17, 20-lyase-inhibiting activity |
12/08/1994 | CA2161979A1 Cloning, expression and uses of dorsalin-1 |
12/08/1994 | CA2140519A1 Taxane having antitumor activity |
12/07/1994 | EP0627489A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated |
12/07/1994 | EP0626964A1 Heterocyclic compounds for enhancing antitumor activity |
12/07/1994 | EP0626963A1 Vinylene-azaindole derivatives and process for their preparation |
12/07/1994 | EP0626955A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
12/07/1994 | EP0626953A1 Novel sidechain-bearing taxanes and intermediates thereof |
12/07/1994 | EP0626943A1 Bistriazenes as chemotherapeutic agents |
12/07/1994 | EP0626940A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
12/07/1994 | EP0626937A1 Novel antitumor compound, compositions and method of use |
12/07/1994 | EP0626864A1 Topical composition containing hyaluronic acid and nsaids |
12/07/1994 | EP0416035B1 Amphiphilic peptides and use thereof |
12/06/1994 | USRE34805 Benzonaphthalene derivatives and their use in therapeutic and cosmetic compositions |
12/06/1994 | US5371219 Imidazopyridazine derivatives |
12/06/1994 | US5371204 Interleukins |
12/06/1994 | US5370991 Cloned gene encoding human monocyte elastase inhibitor |
12/06/1994 | US5370873 Therapeutic compounds derived from the neem tree |
12/06/1994 | CA1333442C Wavelength-specific cytotoxic agents |
12/05/1994 | CA2125080A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors |
11/30/1994 | EP0626389A1 Recombinant antibodies specific for TNF-alpha |
11/30/1994 | EP0626385A1 Tetrahydropyran derivatives |